Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New York Blood Center is a large independent nonprofit blood center and healthcare organization focused on blood collection, blood product distribution, transfusion-related laboratory and clinical services, cord blood banking, and hematology research. Founded in 1964, it operates today within the broader New York Blood Center Enterprises organization, which has national reach through multiple blood center divisions. The organization supplies blood and stem cell products, provides specialized laboratory and consultative services to hospitals and healthcare providers, and conducts basic, translational, epidemiologic, and clinical research through the Lindsley F. Kimball Research Institute. Its activities span donor operations, apheresis and cell saver services, comprehensive cell solutions, and the National Cord Blood Program. For a biotech or healthcare analyst, NYBC is best understood as a mission-driven blood banking and transfusion medicine enterprise rather than a traditional drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New York Blood Bank.